FairValueLabs Valuation System Value Investment
TRV

The Travelers Companies, Inc. (TRV) Stock Analysis — Fair Value, Risk & Moat Rating

NYQ · Financial Services · Insurance - Property & Casualty

$301.68 Watch Zone 0.26 (0.1%) As of Apr 22, 2026 Not a buy/sell recommendation. See disclaimer.
Overall Verdict Caution
N/A
Altman Z-ScoreNot applicable to this sector
$312.91
Fair ValueWatch Zone (3.6%)
N/A
Moat RatingNot applicable to this sector
TL;DR · Audit Summary

Is The Travelers Companies, Inc. a safe investment right now?

The Travelers Companies, Inc. is in the Financial Services sector — Altman Z-Score does not apply to this type of company. Our fair value estimate is $312.91 (Watch Zone).

Price Chart · TRV
Section 01 · Financial Health

Why the Altman Z-Score does not apply to The Travelers Companies, Inc.

The Altman Z-Score is designed for manufacturing and non-financial companies. It uses ratios like Working Capital / Total Assets and Revenue / Total Assets that produce misleading results for Financial Services companies.

  • Banks hold massive assets (loans) that inflate Total Assets, making WC/TA nearly zero — a false distress signal
  • Utilities carry high regulated debt by design — the model misreads leverage as risk
  • REITs use Funds From Operations (FFO), not Free Cash Flow — standard cash flow analysis doesn't apply

Altman Z-Score is designed for manufacturing companies and does not apply to banks, utilities, or REITs.

Note: A sector-specific financial health model for Financial Services companies is planned for a future update.

Section 02 · Fair Value Estimate

What is The Travelers Companies, Inc. actually worth?

FVL Fair Value$312.91
vs
Market Price$301.68
Watch Zone 3.6% Stock trades 3.6% below analyst consensus fair value of $312.91.

How we calculated this

FVL Valuation Model
InputValueSource
Analyst Consensus Target$312.9122 Wall Street analysts
Analyst High / Low$350.00 / $250.00Range of analyst price targets
Price / Book1.99xCurrent market valuation vs book value
Return on Equity25.3%Profitability relative to shareholder equity

Source: Earnings data from SEC EDGAR filings. Market data via Yahoo Finance.

Section 03 · Competitive Moat

Why standard moat analysis does not apply to The Travelers Companies, Inc.

Our standard moat model uses ROIC stability, gross margin trends, and switching costs — metrics designed for product and service companies. Financial Services companies compete on fundamentally different dimensions.

  • Banks — moat comes from deposit cost advantage, net interest margin stability, and fee income diversification
  • Utilities — moat is a regulatory monopoly with guaranteed rate of return on invested capital
  • REITs — moat comes from property portfolio quality, location, tenant mix, and cap rate advantages

Standard moat analysis (ROIC/gross margin/switching costs) does not reliably apply to Financial Services companies. Banks compete on net interest margin, utilities on regulated returns, and REITs on occupancy and cap rates.

Note: A sector-specific competitive analysis for Financial Services companies is planned for a future update.

Section 04 · Dividend Safety

Is The Travelers Companies, Inc.'s dividend safe?

A Dividend Safety Grade
Yield1.5%
Payout Ratio13.1%
Consecutive Years40
5Y Growth Rate-20.6%

Can The Travelers Companies, Inc. afford its dividend?

Payout ratio is 13.1%. FCF covers the dividend 7.4x. 40 consecutive years of payments.

Section 05 · Financial Summary

The Travelers Companies, Inc.'s key financial metrics

TRV financial summary
MetricLatest1Y Ago3Y AgoTrend
Revenue $48.8B $46.4B $36.9B Rising
Net Income $6.3B $5.0B $2.8B Rising
Free Cash Flow $10.6B $9.1B $6.5B Rising
Section 06 · Lab Signals

Recent events that affect our TRV analysis

EARNINGS

TRV earnings report scheduled

Lab Impact

Upcoming report. Consensus EPS estimate: $4.82. Revenue estimate: $10.97B. Our current Fair Value: $312.91 — a significant beat or miss could shift this estimate.

ANALYST

TRV analyst consensus: 30% bullish (8 of 27 analysts)

Lab Impact

2 Strong Buy, 6 Buy, 16 Hold, 0 Sell, 3 Strong Sell. Consensus target: $312.91 (3.7% upside). Compare with our independent Fair Value: $312.91.

EARNINGS

TRV beat EPS estimates by 8.9%

Lab Impact

Reported EPS: $7.71 vs estimate $7.08. Earnings strength supports our Fair Value of $312.91 (3.7% above current price).

FILING

TRV filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

FILING

TRV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

DIVIDEND

TRV paid $1.1000/share dividend

Lab Impact

Dividend Safety Grade: A. Payout ratio: 13.1%.

FILING

TRV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

TRV filed annual report (10-K)

Lab Impact

Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →

FILING

TRV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

EARNINGS

TRV beat EPS estimates by 26.4%

Lab Impact

Reported EPS: $11.13 vs estimate $8.80. Earnings strength supports our Fair Value of $312.91 (3.7% above current price).

FILING

TRV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

DIVIDEND

TRV paid $1.1000/share dividend

Lab Impact

Dividend Safety Grade: A. Payout ratio: 13.1%.

EARNINGS

TRV beat EPS estimates by 27.6%

Lab Impact

Reported EPS: $8.14 vs estimate $6.38. Earnings strength supports our Fair Value of $312.91 (3.7% above current price).

FILING

TRV filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

FILING

TRV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

DIVIDEND

TRV paid $1.1000/share dividend

Lab Impact

Dividend Safety Grade: A. Payout ratio: 13.1%.

FILING

TRV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

EARNINGS

TRV beat EPS estimates by 80.1%

Lab Impact

Reported EPS: $6.51 vs estimate $3.61. Earnings strength supports our Fair Value of $312.91 (3.7% above current price).

FILING

TRV filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

FILING

TRV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

DIVIDEND

TRV paid $1.1000/share dividend

Lab Impact

Dividend Safety Grade: A. Payout ratio: 13.1%.

FILING

TRV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

TRV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

EARNINGS

TRV beat EPS estimates by 147.7%

Lab Impact

Reported EPS: $1.91 vs estimate $0.77. Earnings strength supports our Fair Value of $312.91 (3.7% above current price).

FILING

TRV filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

FILING

TRV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

DIVIDEND

TRV paid $1.0500/share dividend

Lab Impact

Dividend Safety Grade: A. Payout ratio: 13.1%.

FILING

TRV filed annual report (10-K)

Lab Impact

Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →

FILING

TRV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

TRV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

EARNINGS

TRV beat EPS estimates by 38.5%

Lab Impact

Reported EPS: $9.15 vs estimate $6.60. Earnings strength supports our Fair Value of $312.91 (3.7% above current price).

FILING

TRV filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

Section 07 · FAQ

Common questions about The Travelers Companies, Inc.

What is The Travelers Companies, Inc. stock price today?

The Travelers Companies, Inc. (TRV) stock price is $301.68 as of the latest market close, traded on the NYSE exchange.

What does The Travelers Companies, Inc. do?

The Travelers Companies, Inc., through its subsidiaries, provides a range of commercial and personal property, and casualty insurance products and services to businesses, government units, associations, and individuals in the United States, Canada, and internationally. It operates through three segments: Business Insurance, Bond & Specialty Insurance, and Personal Insurance. The Business Insurance segment offers workers' compensation, commercial automobile and property, general liability, commercial multi-peril, employers' liability, public and product liability, professional indemnity, marine, aviation, commercial property and automobile, onshore and offshore energy, construction, terrorism, personal accident, and kidnap and ransom insurance products.

What is The Travelers Companies, Inc. market cap?

The Travelers Companies, Inc. has a market capitalization of $64.15B, classifying it as a large-cap stock in the Financial Services sector.

What sector and industry is TRV in?

The Travelers Companies, Inc. operates in the Financial Services sector, specifically within the Insurance - Property & Casualty industry. It trades on the NYSE under the ticker symbol TRV.

Is TRV stock overvalued or undervalued?

Based on our valuation model, The Travelers Companies, Inc. trades 3.6% below our fair value estimate — potentially undervalued.

  • FairValueLabs Fair Value: $312.91
  • Current Price: $301.68
  • Valuation Zone: Watch Zone
What is TRV stock forecast and analyst target price?

Based on 22 Wall Street analysts, the consensus price target for The Travelers Companies, Inc. is $312.91, implying upside of 3.7% from the current price.

  • Analyst High Target: $350.00
  • Analyst Low Target: $250.00

Note: Analyst targets are shown for reference and are not used in our valuation model.

Is The Travelers Companies, Inc. revenue and earnings growing?

Here are the analyst consensus growth estimates for The Travelers Companies, Inc.:

  • Revenue growth (current year est.): -0.4%
  • EPS growth (current year est.): 1.7%
  • Revenue growth (next year est.): 2.9%
  • EPS growth (next year est.): 1.3%
What are The Travelers Companies, Inc.'s key financial metrics?
MetricLatestTrend
Revenue$48.8BRising
Net Income$6.3BRising
Free Cash Flow$10.6BRising
What is TRV's P/E ratio?

The price-to-earnings ratio measures how much investors pay per dollar of earnings:

  • Trailing P/E (last 12 months): 9.0x
  • Forward P/E (next 12 months est.): 10.6x
How volatile is TRV stock?

The Travelers Companies, Inc. has a beta of 0.52, meaning it is less volatile than the broader market. A beta above 1.0 indicates higher price swings relative to the S&P 500, while below 1.0 suggests more stability.

How much cash and debt does The Travelers Companies, Inc. have?

The Travelers Companies, Inc.'s balance sheet shows:

  • Total Cash: $7.14B
  • Total Debt: $9.27B
  • Net Cash Position: $-2.13B

A positive net cash position means the company holds more cash than debt, reducing financial risk.

What is The Travelers Companies, Inc.'s free cash flow?

The Travelers Companies, Inc. generated $13.30B in trailing twelve-month free cash flow (from $11.44B in operating cash flow). Free cash flow represents the cash available for dividends, buybacks, and debt reduction after all capital expenditures.

Does The Travelers Companies, Inc. pay a dividend, and is it safe?

Yes, The Travelers Companies, Inc. pays a regular dividend. Here are the key metrics:

  • Dividend Yield: 1.5%
  • Payout Ratio: 13.1%
  • Consecutive Years Paid: 40
  • 5-Year Dividend Growth: -20.6%
  • FairValueLabs Safety Grade: A
Is The Travelers Companies, Inc. financially healthy?

The Altman Z-Score — the standard bankruptcy prediction model — is not applicable to Financial Services companies like The Travelers Companies, Inc.. The formula uses ratios designed for manufacturing firms that produce misleading results for banks, utilities, and REITs.

Does The Travelers Companies, Inc. have a competitive moat?

Our standard moat model (based on ROIC, gross margins, and switching costs) does not apply to Financial Services companies. These firms compete on fundamentally different dimensions such as regulatory advantages, deposit cost structures, or property portfolios.

What is TRV's return on equity (ROE)?

The Travelers Companies, Inc.'s return on equity is 25.3%. ROE measures how efficiently a company generates profits from shareholder equity. An ROE above 15% is generally considered strong, while below 10% may signal inefficiency.

How do I buy TRV stock?

TRV shares can be purchased through any brokerage account that provides access to the NYSE. Common steps:

  1. Open an account with a broker (e.g., Fidelity, Schwab, Interactive Brokers)
  2. Search for ticker symbol TRV
  3. Place a market or limit order for your desired number of shares

This is not investment advice. Always do your own research before buying any stock.

Is TRV a value stock or speculative?

FairValueLabs classifies The Travelers Companies, Inc. as Value Investment. It exhibits consistent profitability, reasonable valuation, and financial stability — characteristics of a traditional value investment.

Who is the CEO of The Travelers Companies, Inc.?

The current CEO of The Travelers Companies, Inc. is Mr. Alan David Schnitzer J.D..

What is TRV's earnings per share (EPS)?

Earnings per share measures the company's profit allocated to each outstanding share:

  • Trailing EPS (last 12 months): $33.52
  • Forward EPS (next 12 months est.): $28.42
  • Analyst consensus EPS (this year): $28.05
  • Analyst consensus EPS (next year): $28.42

FairValueLabs Disclaimer

All valuations, scores, ratings, and classifications on this page are produced by the FairValueLabs internal valuation system. They do not represent actual market value, guaranteed outcomes, or professional investment advice. These are analytical estimates for educational and research purposes only.

This is not financial advice. All data is sourced from SEC EDGAR public filings. Always consult a qualified financial advisor before making investment decisions.

Last updated: Apr 22, 2026. Data sources: SEC EDGAR (financial statements), Yahoo Finance (market data, analyst consensus). Data may not reflect the most recent quarter.

TRV analysis methodology: How we calculate fair value, Z-Scores, and moat ratings